Clinical Trials on Folliculotropic Mycosis Fungoides
Total 7544 results
-
European Organisation for Research and Treatment...TerminatedLymphomaSpain, Finland, France, Germany, Switzerland, Belgium, Netherlands, Italy, Israel, Denmark, Hungary, United Kingdom, Austria
-
Yaupon TherapeuticsCompletedMycosis FungoidesUnited States
-
Bispebjerg HospitalTerminatedMycosis Fungoides
-
H. Lee Moffitt Cancer Center and Research InstituteKyowa Hakko Kirin Pharma, Inc.Recruiting
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityUnknown
-
European Organisation for Research and Treatment...CompletedLymphomaGermany, Switzerland, Israel, United Kingdom, Austria, Italy
-
National Cancer Institute (NCI)UnknownLymphomaSouth Africa
-
University of WashingtonCompleted
-
National Cancer Institute (NCI)TerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides/Sezary SyndromeUnited States
-
University of CologneUnknownCD30 Positive Cutaneous T Cell Lymphoma | CD30 Positive Transformed Mycosis FungoidesGermany
-
M.D. Anderson Cancer CenterRecruitingMycosis Fungoides | Lymphomatoid PapulosisUnited States
-
Icahn School of Medicine at Mount SinaiPfizerRecruiting
-
Centre for Human Drug Research, NetherlandsRecordati Rare DiseasesCompleted
-
Northwestern UniversityNational Cancer Institute (NCI); Eli Lilly and CompanyTerminated
-
Northwestern UniversityNational Cancer Institute (NCI)Completed
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous... and other conditionsUnited States, Canada
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Ronald LevyAmerican Society of Clinical Oncology; Lymphoma Research FoundationCompletedMycosis Fungoides | Non-Hodgkin LymphomaUnited States
-
AHS Cancer Control AlbertaNot yet recruiting
-
Stanford UniversityRecruitingNon-Hodgkin's Lymphoma | Mycosis FungoidesUnited States, China, Argentina, Australia, Brazil, Japan, United Kingdom
-
M.D. Anderson Cancer CenterCompletedHematologic Neoplasms | Lymphoma, T-Cell | Mycosis FungoidesUnited States
-
Columbia UniversityMallinckrodt, Inc.RecruitingMycosis Fungoides | Cutaneous T Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMycosis Fungoides | Localized Skin LesionUnited States
-
4SC AGActive, not recruitingLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeAustria, Spain, Germany, United Kingdom, France, Belgium, Japan, Switzerland, Italy, Poland, Netherlands, Greece
-
Thomas Jefferson UniversityActelionUnknownMycosis Fungoides | Cutaneous T-cell Lymphoma
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Emergent Product Development Seattle LLCTerminatedMycosis Fungoides | Sezary SyndromeUnited States, Spain, France, Germany, Italy
-
Latin American Cooperative Onco-Haematology Group...UnknownMycosis Fungoides | Sezary SyndromePeru
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMycosis Fungoides | Cutaneous T Cell Lymphoma
-
Stanford UniversityRecruitingMycosis Fungoides | Sezary SyndromeUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMycosis Fungoides | Sezary SyndromeUnited States
-
Myeloid TherapeuticsSuspendedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Lymphoma, T-Cell, Peripheral | Cell Therapy | Adoptive Cellular ImmunotherapyUnited States
-
Eisai Inc.CompletedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeGermany, Canada, Australia, United Kingdom, Austria, Russian Federation, United States, Poland, Switzerland
-
Kyowa Kirin China Pharmaceutical Co., Ltd.Recruiting
-
Northwestern UniversityGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.Completed
-
Northwestern UniversityNational Cancer Institute (NCI)Terminated
-
Northwestern UniversityNational Cancer Institute (NCI)Terminated
-
Eisai Inc.CompletedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary SyndromeGermany, Canada, United Kingdom, Austria, Russian Federation, United States, Australia, Poland, Switzerland, Netherlands
-
Sorrento Therapeutics, Inc.RecruitingMycosis FungoidesUnited States
-
Rochester General HospitalBausch Health Americas, Inc.; Rochester Skin Lymphoma Medical Group, PLLCWithdrawn
-
University of California, DavisCompletedPsoriasis | Mycosis FungoidesUnited States
-
University of Texas Southwestern Medical CenterWithdrawnCutaneous T-Cell LymphomasUnited States
-
Virginia Commonwealth UniversitySeagen Inc.CompletedMycosis Fungoides | Sézary SyndromeUnited States
-
Lund University HospitalRecruitingMycosis Fungoides | Sezary SyndromeSweden
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.RecruitingMycosis Fungoides | Sezary Syndrome | Lymphomatoid PapulosisUnited States
-
4SC AGCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T Cell LymphomaUnited Kingdom
-
National Cancer Institute (NCI)TerminatedNeoplasms | Mycosis Fungoides | Cutaneous T-Cell LymphomaUnited States
-
Elorac, Inc.TerminatedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sézary SyndromeUnited States